Evolutionary Genomics, Inc. (FNAM)
FNAM Stock Price Chart
Explore Evolutionary Genomics, Inc. interactive price chart. Choose custom timeframes to analyze FNAM price movements and trends.
FNAM Company Profile
Discover essential business fundamentals and corporate details for Evolutionary Genomics, Inc. (FNAM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 May 2012
Employees
2.00
Website
https://www.evolgen.comCEO
Steve B. Warnecke
Description
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
FNAM Financial Timeline
Browse a chronological timeline of Evolutionary Genomics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Nov 2024
Earnings released on 28 Aug 2024
Earnings released on 10 May 2024
Earnings released on 12 Feb 2024
Earnings released on 27 Nov 2023
Earnings released on 30 May 2023
Earnings released on 8 Apr 2023
Earnings released on 9 Mar 2023
EPS came in at -$0.04 .
Earnings released on 21 Oct 2022
EPS came in at -$0.08 .
Earnings released on 8 Aug 2022
EPS came in at -$0.08 .
Earnings released on 16 May 2022
EPS came in at -$0.09 .
Earnings released on 21 Mar 2022
EPS came in at -$0.11 .
Earnings released on 1 Nov 2021
EPS came in at -$0.18 .
Earnings released on 6 Aug 2021
EPS came in at -$0.09 .
Earnings released on 13 May 2021
EPS came in at -$0.09 .
Earnings released on 31 Mar 2021
EPS came in at -$0.29 , while revenue for the quarter reached -$12.50K .
Earnings released on 13 Nov 2020
EPS came in at $0.09 .
FNAM Stock Performance
Access detailed FNAM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.